Kinnunen E, Junttila O, Haukka J, Hovi T
Department of Neurology, Hyvinkää Hospital, Finland.
Am J Epidemiol. 1998 Jan 1;147(1):69-73. doi: 10.1093/oxfordjournals.aje.a009369.
A retrospective analysis of the incidence of Guillain-Barré syndrome (GBS) in Finland in 1981-1986 was carried out by careful examination of medical records identified from nationwide Hospital Discharge Register data based on a mean total population of 5 million people. Records from 247 patients fulfilled the accepted criteria of GBS corresponding to a mean annual incidence of 0.82 per 100,000 population. Monthly rates showed an increased incidence of GBS in March 1985, following by a few weeks the onset of the nationwide oral poliovirus vaccine campaign and partly overlapping it. Analysis of the time series in depth suggested, however, that a change point in the occurrence of GBS had already taken place before the oral poliovirus vaccine campaign. Widespread circulation of wild-type 3 poliovirus in the population immediately preceded the oral poliovirus vaccine campaign and the peak occurrence of GBS. These results demonstrate a temporal association between poliovirus infection, caused by either wild virus or live attenuated vaccine, and an episode of increased occurrence of GBS, but they cannot prove the suspected cause-effect relation between GBS and oral poliovirus vaccine administration.
通过仔细查阅基于平均总人口500万的全国医院出院登记数据所确定的病历,对1981 - 1986年芬兰吉兰 - 巴雷综合征(GBS)的发病率进行了回顾性分析。247例患者的病历符合GBS的公认标准,对应年平均发病率为每10万人0.82例。月度发病率显示,1985年3月GBS发病率有所上升,几周后全国口服脊髓灰质炎病毒疫苗接种运动开始,二者部分时间重叠。然而,对时间序列的深入分析表明,GBS发病的一个变化点在口服脊髓灰质炎病毒疫苗接种运动之前就已经出现。野生3型脊髓灰质炎病毒在人群中的广泛传播紧接在口服脊髓灰质炎病毒疫苗接种运动和GBS发病高峰之前。这些结果表明,由野生病毒或减毒活疫苗引起的脊髓灰质炎病毒感染与GBS发病率增加的一段时期之间存在时间关联,但它们不能证明GBS与口服脊髓灰质炎病毒疫苗接种之间存在可疑的因果关系。